Compare STOK & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | CCS |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2019 | 2014 |
| Metric | STOK | CCS |
|---|---|---|
| Price | $32.81 | $55.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $39.20 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 795.5K | 211.7K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | ★ 92.73 | N/A |
| EPS | N/A | ★ 4.86 |
| Revenue | $184,420,000.00 | ★ $4,117,816,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $82.05 | $10.84 |
| P/E Ratio | ★ N/A | $11.81 |
| Revenue Growth | ★ 404.50 | N/A |
| 52 Week Low | $5.35 | $50.42 |
| 52 Week High | $40.22 | $76.00 |
| Indicator | STOK | CCS |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 29.16 |
| Support Level | $31.02 | $51.84 |
| Resistance Level | $35.75 | $57.48 |
| Average True Range (ATR) | 2.42 | 1.69 |
| MACD | -0.29 | -0.00 |
| Stochastic Oscillator | 28.66 | 19.36 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.